Rezultati - Cathy Andorfer
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
-
5
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis od Sahra Borgés, Heike Döppler, Edith A. Perez, Cathy Andorfer, Zhifu Sun, Panos Z. Anastasiadis, E. Aubrey Thompson, Xochiquetzal J. Geiger, Peter Störz
Izdano 2013Artigo -
6
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer od Luigi Strizzi, Katharine M. Hardy, Naira V. Margaryan, David W. Hillman, Elisabeth A. Seftor, Beiyun Chen, Xochiquetzal J. Geiger, E. Aubrey Thompson, Wilma L. Lingle, Cathy Andorfer, Edith A. Perez, Mary J.C. Hendrix
Izdano 2012Artigo -
7
Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy od Zdenek Berger, Hanno M. Roder, Amanda Hanna, Aaron Carlson, Vijayaraghavan Rangachari, Mei Yue, Zbigniew K. Wszołek, Karen H. Ashe, Joshua A. Knight, Dennis W. Dickson, Cathy Andorfer, Terrone L. Rosenberry, Jada Lewis, Mike Hutton, Christopher Janus
Izdano 2007Artigo -
8
Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors od Brian M. Necela, Jennifer A. Crozier, Cathy Andorfer, Laura J. Lewis‐Tuffin, Jennifer M. Kachergus, Xochiquetzal J. Geiger, Krishna R. Kalari, Daniel Serie, Zhifu Sun, Alvaro Moreno Aspita, Daniel J. O’Shannessy, Julia D. Maltzman, Ann E. McCullough, Barbara A. Pockaj, Heather E. Cunliffe, Karla V. Ballman, E. Aubrey Thompson, Edith A. Perez
Izdano 2015Artigo -
9
Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027 od Donna M. Barten, Patrizia Fanara, Cathy Andorfer, Nina Hoque, Po‐yin Anne Wong, Kristofor H. Husted, Gregory Cadelina, Lynn B. DeCarr, Lingwei Yang, Victoria Liu, Chancy Fessler, Joan Protassio, Timothy Riff, Holly Turner, Christopher Janus, Sethu Sankaranarayanan, Craig Polson, Jere E. Meredith, G. T. Gray, Amanda Hanna, Richard E. Olson, Soong‐Hoon Kim, Gregory D. Vite, Francis Y. Lee, Charles F. Albright
Izdano 2012Artigo -
10
<i>C-MYC</i> Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Tr... od Edith A. Perez, Robert B. Jenkins, Amylou C. Dueck, Anne E. Wiktor, Patrick P. Bedroske, S. Keith Anderson, Rhett P. Ketterling, William R. Sukov, Kazunori Kanehira, Beiyun Chen, Xochiquetzal J. Geiger, Cathy Andorfer, Ann E. McCullough, Nancy E. Davidson, Silvana Martino, George W. Sledge, Peter A. Kaufman, Leila A. Kutteh, Julie R. Gralow, Lyndsay N. Harris, James N. Ingle, Wilma L. Lingle, Monica M. Reinholz
Izdano 2011Artigo
Iskalna orodja:
Sorodne teme
Medicine
Biology
Internal medicine
Breast cancer
Cancer
Gene
Oncology
Disease
Genetics
Pathology
Alzheimer's disease
Biochemistry
Cancer research
Immunology
Neurodegeneration
Neuroscience
Tau protein
Adjuvant
Cell biology
Genetically modified mouse
Immune system
Immunohistochemistry
Pathogenesis
Tauopathy
Transgene
Triple-negative breast cancer
Adjuvant therapy
Apoptosis
Autoimmune disease
Bioinformatics